Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
171,757,851
-
Share change
-
+170,420
-
Total reported value
-
$40,049,515,897
-
Put/Call ratio
-
104%
-
Price per share
-
$233.29
-
Number of holders
-
1,076
-
Value change
-
+$49,626,361
-
Number of buys
-
463
-
Number of sells
-
409
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2019
As of 31 Dec 2019,
Edwards Lifesciences Corp - Common Stock (EW) was held by
1,076 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
171,757,851 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, Bank of New York Mellon Corp, SANDS CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, Capital Research Global Investors, WELLINGTON MANAGEMENT GROUP LLP, and Capital International Investors.
This page lists
1,078
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.